Across TCGA pan-cancer cohorts, IGHVIII-67-4 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated IGHVIII-67-4 data layer.
The strongest signal is observed in testicular germ cell tumors (TGCT), where higher IGHVIII-67-4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated IGHVIII-67-4 expression acts as an unfavorable survival marker, although some lineages such as LUAD and ESCA show a favorable association.
TGCT, GBM, and PCPG are the cancer types where IGHVIII-67-4 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.